Louis Portugal
Otolaryngology · Chicago, ILNPI 1114937091
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,668 of the $67,788 with a category attached, or 68.8%. 7 manufacturers reported payments, led by Intersect ENT, Inc. at 35.7% of the total. Reporting peaked in 2020 at $19,242 and has fallen 60.6% since, to $7,584 in 2025. Among otolaryngology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $954.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$24K
- Davol Inc.$16K
- Aerin Medical Inc.$12K
- Medtronic$9K
- BD$6K
- Regeneron Healthcare Solutions, Inc.$122
- plus $90 from 1 others
What the payments were for
- Consulting fees$11,80017%
- Speaking & faculty fees$46,66869%
- Travel & lodging$7,50111%
- Food & beverage$1,8193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 18 | $24,225 |
| Davol Inc. | 13 | $16,320 |
| Aerin Medical Inc. | 14 | $12,488 |
| Medtronic | 13 | $8,728 |
| BD | 10 | $5,815 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Stryker | 2 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$12,353
- PROPEL$1,335
- SINUVA$972
- RHINAER STYLUS$553
How this compares
$67,788 in reported general payments places this provider in the 95th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 455 | $4,749 |
| Fluticasone Propionate | 292 | $4,193 |
| Azelastine Hcl | 150 | $3,261 |
| Omeprazole | 255 | $2,136 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 151 | $1,188 |
| Methylprednisolone | 116 | $614 |
| Fluconazole | 28 | $195 |
| Ciprofloxacin Hcl | 27 | $127 |
| Doxycycline Hyclate | 15 | $89 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $81 |
| Montelukast Sodium | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chicago
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Victoria LeeChicago$86K
- Dean ToriumiChicago$63K
- Monica PatadiaChicago$56K
- Phillip LosavioChicago$53K
- Fuad BaroodyChicago$46K
- Bruce TanChicago$44K
- Mihir BhayaniChicago$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.